Keeping Current

500 episodes listed below

Listen to the show on

Certified clinical updates for practice decisions.

The gist

Keeping Current packages certified medical education into focused clinical presentations, often with faculty disclosures, learning objectives, post-tests, and supporting resources. Recent episodes move from dual SGLT inhibition in heart failure to MASH, obesity care, inhaler adherence, metastatic breast cancer, uveitic macular edema, and aging with HIV.

PRESS PLAY

Find your next episode

All episodes

About Keeping Current

Keeping Current is a medical education show built for clinicians, not a general wellness audience. Its rhythm is formal and purposeful. Episodes often open with faculty disclosures, learning objectives, post-test instructions, copyright language, and references to slides or resources. That structure gives the show the feel of a compact conference session delivered through a podcast feed. The subject matter is wide, but the questions are consistently clinical. Recent episodes examine dual SGLT1 and SGLT2 inhibition in heart failure, liver fibrosis in type 2 diabetes and obesity, and emerging hormone-based combination therapies for obesity and diabetes. MASH and MASLD appear as recurring concerns, especially where metabolic disease, obesity, fibrosis, and earlier diagnosis intersect. The show also steps outside endocrinology-adjacent topics when the clinical update demands it. It covers HR+/HER2- metastatic breast cancer, PI3K/AKT pathway inhibitors, uveitic macular edema, respiratory disease, and chronic inflammation in aging people living with HIV. The approach is evidence-first. Faculty describe mechanisms, guideline distinctions, patient selection, therapeutic options, and real-world barriers to care. Some episodes use panel discussion, while others follow a lecture or docu-series format. The inhaler adherence episode is a good example of the show's practical side, moving from device design and inhalation technique to cost, regimen simplicity, symptoms, hospitalization risk, and patient preference. The obesity and liver disease material is similarly grounded, rejecting simplistic lifestyle framing in favor of disease models, progression stages, diagnostics, and effective treatment strategies. Keeping Current rarely chases personality. Its value is in compressed clinical context. The tone stays professional, sometimes dense, and clearly designed for people who already understand medical vocabulary. It suits clinicians and healthcare professionals who want a reliable way to sample current therapeutic debates. The show is strongest when it connects molecular or guideline-level updates to bedside choices. It is not light listening, and it does not pretend to be. It is a practice-improvement feed for keeping medical decisions current.

Made for: Keeping Current is for clinicians and healthcare professionals who are comfortable with specialist terminology and evidence-based treatment discussion. It especially suits professionals tracking changes in metabolic, cardiovascular, respiratory, oncology, ophthalmology, and infectious disease care.

What sets it apart: The show stands apart by packaging podcast episodes as certified educational activities, complete with objectives, disclosures, post-tests, and supporting resources. Its editorial center is not opinion or lifestyle advice, but practical translation of current evidence into clinical care.

In their own words

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Why you'd press play

Clinical guidelines arrive with thresholds attached, so your next patient plan needn't run on vibes.

Press play if you want

  • exact screening cutoffs and follow-up intervals before managing metabolic liver disease
  • treatment evidence separated into endpoints, toxicities, and patient-fit questions
Read the full recommendation in PlayNext →
metabolic disease and obesityMASH, MASLD, and liver fibrosisheart failure therapiesdiabetes treatment conceptsclinical guideline applicationpatient-centered treatment selectionmedication adherence barriersspecialist case-based education

Talks about

Best episodes of Keeping Current

Short reviews from the PlayNext desk, based on the episodes we processed.

From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and ComplianceFeb 27, 2026

A practical clinician-led review of why inhaler treatment can succeed or stall after prescribing.

This Medscape Education Global episode looks at the distance between prescribing an inhaler and seeing it used well in daily care. Omar Osmani leads a practical discussion with Tonya and Amy on device choice, correct technique, adherence, compliance, and what patients actually…

Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts

Obesity care, from guideline basics to the next wave of hormone-based treatment.

Dr. Sue Peterson presents obesity care as a moving target, beginning with obesity prevalence and obesity-associated health conditions before turning to current recommendations for MASH, sleep apnea, and knee osteoarthritis.

Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach

A focused guide to liver workup decisions, with a careful eye on timing and readouts.

The conversation treats MASH as part of metabolic care, not as a liver problem on its own. It follows a patient with obesity and long-standing type 2 diabetes through the questions clinicians actually have to answer: who needs noninvasive testing, when a measurement should be…

Podcasts like Keeping Current

  • Rad ChatNaman Julka-Anderson and Jo McNamara

    Cancer care, told at human speed.

  • SBDcastSBD

    Dermatology conduct, evidence, and specialist judgment.

  • Bloody MindedBloody Minded Crew

    Hematology teaching with bite and bedside utility.

  • The FCP PodcastRichard Tennant

    Case-based clinical reasoning for first contact care.

  • Emerald Coast Medical MasteryEmerald Coast Medical Association

    Local medicine, told through physicians' lives.

  • OncLive® On Air

    Clinical oncology evidence, translated into treatment decisions.

Episodes

  1. 1

    Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

    ·29m
  2. 2

    New Horizons in Uveitic Macular Edema

    ·34m
  3. 3

    Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis

    ·51m
  4. 4

    Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines

    ·37m
  5. 5

    Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers

    ·31m
  6. 6

    Avoiding Common Mistakes in Managing Focal Epilepsy

    ·19m
  7. 7

    From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance

    ·35m
  8. 8

    The CLL Consultation: Partnering With Patients for Person-Centred Care

    ·36m
  9. 9

    Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates

    ·37m
  10. 10

    Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence

    ·34m
  11. 11

    2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer

    ·37m
  12. 12

    A Case-Based Journey From Risk to Results

    ·19m
  13. 13

    HER2-Positive Early Breast Cancer: What the Latest Data Mean for Your Practice

    ·19m
  14. 14

    Balancing ART and Comorbidities in Aging People Living With HIV

    ·27m
  15. 15

    The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology

    ·33m
  16. 16

    Achieving Brain Health in Epilepsy: What Can Clinicians Do?

    ·21m
  17. 17

    Patient Case Challenge: How Would You Manage This Patient With MASH?

    ·18m
  18. 18

    Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies

    ·31m
  19. 19

    Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences

    ·32m
  20. 20

    Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy

    ·34m
  21. 21

    How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies

    ·32m
  22. 22

    Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies

    ·38m
  23. 23

    Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care

    ·30m
  24. 24

    How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?

    ·20m
  25. 25

    Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering

    ·31m
  26. 26

    Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm

    ·32m
  27. 27

    Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data

    ·16m
  28. 28

    Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies

    ·19m
  29. 29

    Coexisting Comorbidities: Advancing Holistic Care in COPD

    ·34m
  30. 30

    Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?

    ·39m
  31. 31

    Latest Advances in mHSPC: An Update From Berlin 2025

    ·20m
  32. 32

    Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC

    ·35m
  33. 33

    Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond

    ·1h 17m
  34. 34

    Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication

    ·38m
  35. 35

    Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC

    ·1h 19m
  36. 36

    The Hidden Battle: Understanding Chronic Inflammation in Aging People Living With HIV and Comorbidities

    ·35m
  37. 37

    Emerging Therapies for MASH: From Theory to Clinical Practice

    ·36m
  38. 38

    Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed?

    ·40m
  39. 39

    Targeting Diabesity From Multiple Angles: Future Prospects and Imminent Realities

    ·16m
  40. 40

    Neovascular AMD: Optimizing Disease Control for Your Patients

    ·28m
  41. 41

    The Hidden Hurdle: Practical Insights on Drug-Drug Interactions in Prostate Cancer Management

    ·44m
  42. 42

    Managing Diabetic Macular Edema in Clinical Practice

    ·34m
  43. 43

    Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers

    ·37m
  44. 44

    Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

    ·29m
  45. 45

    Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway

    ·37m
  46. 46

    Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025

    ·21m
  47. 47

    Under the Skin: Revolutionizing Immunotherapy Delivery in Lung Cancer

    ·16m
  48. 48

    Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy

    ·33m
  49. 49

    Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?

    ·34m
  50. 50

    Illuminating the Path: New Insights in EGFR-Mutated Advanced NSCLC

    ·33m
  51. 51

    Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer

    ·28m
  52. 52

    JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care

    ·20m
  53. 53

    The Basis of Success: Recognizing IgAN and Promoting Earlier Diagnosis to Facilitate Treatment Initiation

    ·31m
  54. 54

    Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression

    ·19m
  55. 55

    Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer

    ·18m
  56. 56

    Long COVID in Context: A Closer Look at Post-Viral Syndrome and Management Approaches

    ·35m
  57. 57

    Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition

    ·28m
  58. 58

    Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach

    ·37m
  59. 59

    ADA 2025 Highlights: The Weight of Evidence for Emerging Combination Therapies in Obesity and Diabetes Care

    ·32m
  60. 60

    Advancing Treatment for HER2-Positive Advanced Breast Cancer: Expert Analysis of the Latest Developments

    ·17m
  61. 61

    Personalized Pathways: Tailoring Care for Patients With Newly Diagnosed Multiple Myeloma

    ·50m
  62. 62

    Quickfire Updates on Gastric/GEJ Cancers: Latest Data in Perioperative Immunotherapy

    ·19m
  63. 63

    IgG-Mediated Autoimmune Disorders: A Clinical Update on Novel Therapies Targeting FcRn

    ·13m
  64. 64

    Breast Cancer Care in 2025: Breakthroughs and Takeaways From Chicago

    ·37m
  65. 65

    Fresh Perspectives in Thyroid Eye Disease

    ·37m
  66. 66

    The Evolution of Antibody-Drug Conjugate Therapy for Gastric/GEJ Cancers: Latest Data and Clinical Implications

    ·35m
  67. 67

    Shared Decision-Making in Epilepsy Today

    ·52m
  68. 68

    Frontline Frontiers: Revolutionizing Extensive-Stage SCLC Care Through Treatment Innovation

    ·36m
  69. 69

    One Team, One Goal: The Key to Better Patient Outcomes in Early Breast Cancer Management

    ·38m
  70. 70

    Collaborative Management of EGFR-Mutated Advanced NSCLC: A Patient–Care Team Journey

    ·51m
  71. 71

    New Considerations in Managing Family Planning in Multiple Sclerosis

    ·55m
  72. 72

    Advancing Precision Oncology: Recent Progress and Future Outlook

    ·39m
  73. 73

    Advanced HER2-Positive Gastric/GEJ Cancers: Expert Insights on Current and Future Strategies

    ·38m
  74. 74

    Decoding PD-L1 Scoring: Guiding Immunotherapy for Gastroesophageal Cancers

    ·38m
  75. 75

    Patient-Centered Paroxysmal Nocturnal Hemoglobinuria Treatment & the Role of Terminal Complement Inhibitors

    ·37m
  76. 76

    Are We Undertreating Depression in People Living With Epilepsy?

    ·16m
  77. 77

    Pearls on Retina Biomarkers for Clinical Practice

    ·18m
  78. 78

    Sharing Expert Minds in Lung Cancer and Lung Neuroendocrine Tumors Delivering Optimal Patient Care

    ·36m
  79. 79

    COVID-19 Antivirals: Real-World Evidence Review

    ·32m
  80. 80

    Should We Be Thinking More About Bile Acids in Progressive Cholestatic Liver Diseases?

    ·24m
  81. 81

    A Year in Review of Antibody-Drug Conjugates for Breast Cancer: Trends, Practice, and Outlook

    ·1h 25m
  82. 82

    Unveiling the Invisible: The Acute and Chronic Burden of Respiratory Syncytial Virus Disease

    ·52m
  83. 83

    How I Treat Advanced Hepatocellular Carcinoma: Mastering Immunotherapy for Optimal Outcomes

    ·31m
  84. 84

    Interdisciplinary Dialogue: A Cardiologist's Guide to Evidence-Based Obesity Care

    ·27m
  85. 85

    Latest Advances in Breast Cancer: Essential Highlights From San Antonio 2024

    ·39m
  86. 86

    Shaping the Future of Advanced Breast Cancer Care: A Deep Dive Into Novel Data and Emerging Therapies

    ·30m
  87. 87

    The Great Debate: Is Seizure Freedom Always Achievable in Focal Epilepsy?

    ·41m
  88. 88

    Advancing Precision Cancer Medicine: Unveiling the Future Frontier

    ·32m
  89. 89

    Lack of Adherence to Basal Insulin: Are Once-Weekly Formulations the Solution?

    ·19m
  90. 90

    COVID-19 and Oral Antivirals: How to Define an Eligible Patient

    ·15m
  91. 91

    Thyroid Eye Disease: All You Need to Know

    ·39m
  92. 92

    Charting New Horizons: Emerging Data and Novel Therapies in Relapsed/Refractory Follicular Lymphoma

    ·37m
  93. 93

    HIV gp120 Importance Beyond Entry: Role in Immune Activation, Inflammation, and Comorbidities

    ·28m
  94. 94

    Evolving Strategies for Metastatic Breast Cancer: A Deep Dive Into Recent Progress

    ·36m
  95. 95

    Immunotherapy for Hepatocellular Carcinomas: Navigating the Dynamic Treatment Landscape

    ·36m
  96. 96

    Navigating PD-L1 Testing and Patient-Centered Treatment of Gastroesophageal Cancer: A Guide for All Oncology Settings

    This educational podcast discusses PD-L1 testing methods and patient-centered treatment approaches for gastroesophageal cancer across different oncology settings.

    ·49m
  97. 97

    Targeted Therapies for NSCLC: Where Are We Today?

    ·38m
  98. 98

    Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts

    Dr.

    ·27m·2 clips
  99. 99

    Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach

    This episode, the final part of the 'Breaking the Silence' series, follows a hypothetical patient in his 50s with obesity and type 2 diabetes to illustrate MASH management.

    ·21m·2 clips
  100. 100

    Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer

    ·36m
  101. 101

    Advancing Uveitic Macular Edema Management: What's New?

    Linda Lim, Nisha Charia and Jennifer Thorne review how uveitic macular edema (UME) is diagnosed with OCT and fluorescein angiography, and why controlling inflammation comes first, using Thorne's "clogged kitchen sink" analogy.

    Sep 28, 2026·32m·2 clips
  102. 102

    Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop

    Sep 28, 2026·36m
  103. 103

    Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care

    Sep 25, 2026·1h
  104. 104

    Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era

    Sep 24, 2026·52m
  105. 105

    Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer

    Sep 22, 2026·36m
  106. 106

    The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies

    Sep 22, 2026·49m
  107. 107

    Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health

    Sep 8, 2026·29m
  108. 108

    The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis

    Sep 4, 2026·42m
  109. 109

    Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start

    Sep 1, 2026·48m
  110. 110

    Myasthenia Gravis Guidelines: A Global View for Local Practice

    Aug 19, 2026·38m
  111. 111

    From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic

    Aug 18, 2026·18m
  112. 112

    Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring

    Aug 14, 2026·42m
  113. 113

    Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?

    Aug 7, 2026·39m
  114. 114

    Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data

    Aug 5, 2026·28m
  115. 115

    Beyond Intervals: The Next Era of Continuous Delivery in Retinal Medicine

    Jul 24, 2026·32m
  116. 116

    When and How Should I Optimize Heart Failure Treatments for My Patients?

    Jul 23, 2026·26m
  117. 117

    The Evolving Diagnostic and Management Landscape for Progressive Familial Intrahepatic Cholestasis

    Jul 21, 2026·36m
  118. 118

    Pharmacological and Combination Interventions for Nicotine Cessation

    Jun 30, 2026·33m
  119. 119

    Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?

    Jun 26, 2026·30m
  120. 120

    The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management

    Jun 26, 2026·18m
  121. 121

    Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice

    Jun 23, 2026·37m
  122. 122

    Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors

    Jun 17, 2026·22m
  123. 123

    Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies

    Jun 17, 2026·23m
  124. 124

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes

    Jun 5, 2026·26m
  125. 125

    The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement

    Jun 2, 2026·29m
  126. 126

    Depression and Neurological Diseases: What's the Link?

    Jun 1, 2026·22m
  127. 127

    What Lies Beneath Generalized Myasthenia Gravis: Exploring Novel Mechanisms of Action of Emerging Therapies

    May 21, 2026·31m
  128. 128

    Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery

    May 21, 2026·1h 16m
  129. 129

    Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure

    May 18, 2026·30m
  130. 130

    Addressing Unmet Needs in the Management of Sjögren's Disease: A Spotlight on Emerging Biologic Therapies

    May 14, 2026·31m
  131. 131

    Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia

    May 1, 2026·36m
  132. 132

    Diabetic Macular Edema: Express Q&A on What's New

    Apr 30, 2026·17m
  133. 133

    The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure

    This educational episode explores the science of SGLT1 and SGLT2 inhibitors, focusing on dual inhibition as a potential advancement in heart failure treatment.

    Apr 13, 2026·17m
  134. 134

    Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach

    This final episode of a Medscape educational series explores liver fibrosis in type 2 diabetes and obesity through expert interviews and case-based approaches, focusing on advances in diagnosing and managing metabolic-associated steatohepatitis (MASH).

    Mar 30, 2026·21m·1 clip
  135. 135

    Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer

    Hidden gem

    Keeping Current presents a clinical discussion led by Peter Schmidt with Frédéric Pinault-Locard and Kevin Kalinsky on PI3K-AKT pathway inhibitors for ER-positive, HER2-negative metastatic breast cancer.

    Mar 23, 2026·36m·2 clips
  136. 136

    Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis

    Keeping Current examines the obesity–liver disease axis through presentations by Carl LaRue, Amreen Dhanani, Elisabetta Bugianesi, and Phil Newsome.

    Mar 18, 2026·51m·2 clips
  137. 137

    New Horizons in Uveitic Macular Edema

    This educational podcast introduces uveitic macular edema, discussing its incidence, prevalence, and risks of vision loss in the context of a certified medical activity.

    Mar 18, 2026·34m·2 clips
  138. 138

    Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines

    Mar 11, 2026·37m
  139. 139

    Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers

    Mar 10, 2026·31m
  140. 140

    Avoiding Common Mistakes in Managing Focal Epilepsy

    Mar 5, 2026·19m
  141. 141

    From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance

    Omar Osmani, Amy Chan, and Tonya Winders examine how dry-powder inhalers, pressurized metered-dose inhalers, soft-mist inhalers, spacers, and nebulizers affect respiratory drug delivery.

    Feb 27, 2026·35m·2 clips
  142. 142

    The CLL Consultation: Partnering With Patients for Person-Centred Care

    Feb 27, 2026·36m
  143. 143

    Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates

    Feb 27, 2026·37m
  144. 144

    Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence

    Feb 19, 2026·34m
  145. 145

    2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer

    Feb 6, 2026·37m
  146. 146

    A Case-Based Journey From Risk to Results

    Feb 2, 2026·19m
  147. 147

    HER2-Positive Early Breast Cancer: What the Latest Data Mean for Your Practice

    Jan 30, 2026·19m
  148. 148

    Balancing ART and Comorbidities in Aging People Living With HIV

    Jan 20, 2026·27m
  149. 149

    Achieving Brain Health in Epilepsy: What Can Clinicians Do?

    Jan 5, 2026·21m
  150. 150

    The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology

    Jan 5, 2026·33m
  151. 151

    Patient Case Challenge: How Would You Manage This Patient With MASH?

    Dec 31, 2025·18m
  152. 152

    Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies

    Dec 24, 2025·31m
  153. 153

    Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences

    Dec 19, 2025·32m
  154. 154

    Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy

    Dec 18, 2025·34m
  155. 155

    How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies

    Dec 12, 2025·32m
  156. 156

    Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies

    Dec 10, 2025·38m
  157. 157

    Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care

    Dec 9, 2025·30m
  158. 158

    How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?

    Dec 5, 2025·20m
  159. 159

    Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering

    Dec 4, 2025·31m
  160. 160

    Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm

    Dec 2, 2025·32m
  161. 161

    Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data

    Nov 27, 2025·16m
  162. 162

    Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies

    Nov 25, 2025·19m
  163. 163

    Coexisting Comorbidities: Advancing Holistic Care in COPD

    Nov 24, 2025·34m
  164. 164

    Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?

    Nov 24, 2025·39m
  165. 165

    Latest Advances in mHSPC: An Update From Berlin 2025

    Nov 20, 2025·20m
  166. 166

    Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC

    Nov 20, 2025·35m
  167. 167

    Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond

    Nov 17, 2025·1h 17m
  168. 168

    Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication

    Nov 17, 2025·38m
  169. 169

    Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC

    Nov 13, 2025·1h 19m
  170. 170

    Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts

    This educational presentation by an endocrinologist explores innovative multiagonism concepts for reshaping obesity and diabetes care, covering prevalence, health conditions, and emerging hormone-based combination therapies.

    Nov 12, 2025·27m
  171. 171

    The Hidden Battle: Understanding Chronic Inflammation in Aging People Living With HIV and Comorbidities

    This educational program discusses the intersection of aging, comorbidities, and chronic inflammation in people with HIV, focusing on patient-centered care for healthy aging.

    Nov 6, 2025·35m
  172. 172

    Emerging Therapies for MASH: From Theory to Clinical Practice

    Nov 3, 2025·36m
  173. 173

    Targeting Diabesity From Multiple Angles: Future Prospects and Imminent Realities

    Oct 31, 2025·16m
  174. 174

    Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed?

    Oct 31, 2025·40m
  175. 175

    Neovascular AMD: Optimizing Disease Control for Your Patients

    Oct 27, 2025·28m
  176. 176

    The Hidden Hurdle: Practical Insights on Drug-Drug Interactions in Prostate Cancer Management

    Oct 22, 2025·44m
  177. 177

    Managing Diabetic Macular Edema in Clinical Practice

    Oct 2, 2025·34m
  178. 178

    Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers

    Sep 23, 2025·37m
  179. 179

    Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

    This educational podcast discusses the use of targeted immunotherapy in treating Thyroid Eye Disease, featuring expert insights from ophthalmologists and an endocrinologist on clinical approaches and patient impact.

    Sep 19, 2025·29m
  180. 180

    Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

    This educational podcast discusses the use of targeted immunotherapy in treating Thyroid Eye Disease, featuring expert insights from ophthalmologists and an endocrinologist on clinical approaches and patient impact.

    Sep 19, 2025·29m
  181. 181

    Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway

    Sep 18, 2025·37m
  182. 182

    Targeted Therapies for NSCLC: Where Are We Today?

    Sep 11, 2025·38m
  183. 183

    One Size Doesn't Fit All: A Practical Guide on How to Personalize Tacrolimus-Based Therapy in Transplant Recipients

    Nov 18, 2024·1h 3m
  184. 184

    HIV, Inflammation, and Clustered Comorbidities: Assessing Risks and Proactive Management

    Nov 11, 2024·38m
  185. 185

    Brain Health and Brain Health Strategies in Epilepsy

    Oct 31, 2024·28m
  186. 186

    Deciphering the Latest Clinical Data for EGFR-Mutated Advanced NSCLC: Unveiling Expert Insights

    Oct 21, 2024·33m
  187. 187

    Amplify and Act: Case-Based Discussions With Heart Failure Experts

    Sep 30, 2024·47m
  188. 188

    Lowering the Cardiovascular Burden With Novel Weight Loss Therapies: An Expert Digest From ESC

    Sep 25, 2024·20m
  189. 189

    The Rise of the Machines: A Quickfire Exploration of Artificial Intelligence and Big Data in Oncology

    Sep 9, 2024·18m
  190. 190

    Undercover Partners: HIV, Immune Activation, and Inflammation

    Aug 29, 2024·27m
  191. 191

    Chikungunya Virus Vaccine: A New Addition to the Travel Vaccine Armamentarium

    Aug 29, 2024·31m
  192. 192

    Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet Therapy

    Aug 19, 2024·32m
  193. 193

    Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation

    Aug 16, 2024·32m
  194. 194

    Selecting Antiseizure Medications and Aiming for Seizure Freedom

    Aug 16, 2024·38m
  195. 195

    Treatment Goals and Targeted Therapies in Myasthenia Gravis

    Aug 12, 2024·31m
  196. 196

    EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway

    Aug 5, 2024·37m
  197. 197

    Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care

    Jul 31, 2024·38m
  198. 198

    Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When?

    Jul 25, 2024·19m
  199. 199

    Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

    Jul 17, 2024·30m
  200. 200

    Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience

    Jul 12, 2024·42m
  201. 201

    Latest Advances in Breast Cancer Care: Highlights From Chicago 2024

    Jul 11, 2024·17m
  202. 202

    Obesity Care: Improving Health Outcomes in Collaboration With the Patient

    Jun 28, 2024·35m
  203. 203

    The Evolution of Incretins – A Revolution in Diabetes Management?

    Jun 27, 2024·36m
  204. 204

    Dengue: A Leading Cause of Travel-Related Fever – Vaccinating Travelers to Endemic Regions

    Jun 26, 2024·21m
  205. 205

    Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care

    Jun 24, 2024·36m
  206. 206

    Multiple Sclerosis Biosimilars in Europe: How to Communicate With Your Patient for Successful Implementation

    Jun 12, 2024·20m
  207. 207

    A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD

    Jun 7, 2024·32m
  208. 208

    Decoding Epilepsy Treatment Strategies: A Case-Based Exploration

    May 31, 2024·21m
  209. 209

    Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management

    May 31, 2024·38m
  210. 210

    Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies

    May 31, 2024·33m
  211. 211

    Delivering Precision Oncology to Patients: From Principles to Practice

    May 31, 2024·32m
  212. 212

    Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice

    May 30, 2024·35m
  213. 213

    Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights

    May 21, 2024·35m
  214. 214

    SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question

    May 13, 2024·28m
  215. 215

    Personalizing Care for Breast Cancer: The Precision Medicine Approach

    Apr 30, 2024·35m
  216. 216

    A Roadmap to Relief: Managing Agitation in Dementia Associated With Alzheimer's Disease

    Apr 29, 2024·1h
  217. 217

    Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow

    Apr 26, 2024·38m
  218. 218

    How I Treat Alagille Syndrome

    Apr 22, 2024·36m
  219. 219

    Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?

    Mar 29, 2024·21m
  220. 220

    Connecting the Clinical Clues of Alagille Syndrome

    Mar 27, 2024·28m
  221. 221

    The Patient With Obesity in Primary Care: Novel Strategies for Sustained Weight Loss and Better Health Outcomes

    Mar 22, 2024·18m
  222. 222

    The Physical Implications of Stigma in People Living With HIV

    Mar 19, 2024·32m
  223. 223

    HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches

    Mar 15, 2024·36m
  224. 224

    The Patient With High CV Risk and Obesity in Cardiology Care: Evidence-Based Strategies for Weight Loss and CV Risk Reduction

    Mar 11, 2024·23m
  225. 225

    Unveiling the Bigger Picture of Alzheimer's Disease: From New Disease Mechanisms to Biomarkers

    Feb 16, 2024·34m
  226. 226

    Lessons Learned in Long COVID: Impact on Patients and Progress in Management

    Feb 15, 2024·39m
  227. 227

    Managing Menopause in Women Living With HIV

    Feb 8, 2024·34m
  228. 228

    Development of Next-Generation Prophylactic Antibodies for COVID-19

    Jan 30, 2024·36m
  229. 229

    Clinical Spotlight: Harnessing the Power of Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

    Jan 29, 2024·38m
  230. 230

    Transitioning Into Adult Care for Adolescents Living With HIV

    Jan 11, 2024·38m
  231. 231

    Exploring the Ongoing Risk of Severe COVID-19 in At-Risk Populations

    Dec 29, 2023·36m
  232. 232

    Cardiovascular Event Reduction in People With Overweight or Obesity -- Evaluating the Evidence

    Dec 29, 2023·37m
  233. 233

    What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio

    Dec 28, 2023·31m
  234. 234

    Advanced NSCLC: Multidisciplinary and Patient Thoughts on How to Ease the Burden of Care

    Dec 21, 2023·33m
  235. 235

    The Hidden Epidemic: Spotlight on the Unseen Impact of RSV on Adult Health

    Dec 19, 2023·50m
  236. 236

    Next-Generation Monoclonal Antibodies for COVID-19: A Clinical Update

    Dec 18, 2023·38m
  237. 237

    Influenza in Children: Expert Insights on the Current Burden of Disease

    Dec 14, 2023·15m
  238. 238

    Complexities of Cardiometabolic Disease in People Living With HIV

    Dec 13, 2023·37m
  239. 239

    Optimizing Long-Term Management of Generalized Pustular Psoriasis: Are You Up to Date?

    Dec 13, 2023·36m
  240. 240

    New Therapies in Geographic Atrophy: First Experiences from US Clinical Practice

    Dec 7, 2023·33m
  241. 241

    Preventing Respiratory Syncytial Virus in Infants: Understanding Evolving Epidemiology, Assessing Risk, and Protecting the Vulnerable

    Dec 5, 2023·31m
  242. 242

    The Importance of Maintaining Respiratory Syncytial Virus Protection in At-Risk Infants via Passive Immunization

    Dec 5, 2023·31m
  243. 243

    Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

    Dec 4, 2023·33m
  244. 244

    Testing and Timing for COVID-19 Therapies: Understanding Factors for Optimization

    Nov 29, 2023·18m
  245. 245

    Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

    Nov 27, 2023·1h 11m
  246. 246

    Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy

    Nov 23, 2023·49m
  247. 247

    Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care

    Nov 16, 2023·36m
  248. 248

    Diabetes Dialogue: Can We Reduce the Disease Burden with Weekly Basal Insulin?

    Nov 14, 2023·19m
  249. 249

    Understanding the Role of Biologics in Hidradenitis Suppurativa: A Journal Club Review of Recent Data and Clinical Impacts

    Nov 9, 2023·32m
  250. 250

    The Evolving Treatment Landscape for Patients With Psoriatic Disease

    Nov 8, 2023·35m
  251. 251

    Value of Influenza Vaccination in Children: Impact on Transmission and Burden in the Whole Population

    Nov 1, 2023·34m
  252. 252

    Neurocognitive Disorders in People Living With HIV: Cause and Consequence

    Oct 31, 2023·36m
  253. 253

    New Therapies for Neovascular AMD and DME: What Have We Learned?

    Oct 31, 2023·28m
  254. 254

    Identifying Progressive Pulmonary Fibrosis on Imaging and Collaborating With the Multidisciplinary Team

    Oct 30, 2023·38m
  255. 255

    CD19-Targeting in Relapsed/Refractory DLBCL: Optimizing the Use of Noncellular Therapies

    Oct 23, 2023·27m
  256. 256

    Demystifying Drug-Drug Interactions for COVID-19 Antivirals

    Oct 23, 2023·32m
  257. 257

    Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia

    Oct 17, 2023·34m
  258. 258

    Dengue Vaccination in Endemic Populations: Implementation Strategies in Diverse Settings

    Oct 11, 2023·31m
  259. 259

    Neprilysin Inhibition: In Heart Failure and Beyond

    Sep 29, 2023·35m
  260. 260

    What Are the Patients' Unmet Needs in C3 Glomerulopathy? Clinical Pearls on Current Management and Future Perspectives

    Sep 29, 2023·38m
  261. 261

    When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend

    Sep 29, 2023·31m
  262. 262

    Epilepsy and Depression: Managing Common Situations

    Sep 29, 2023·16m
  263. 263

    Hot Topics in Breast Cancer Clinical Research: Challenges, Opportunities, and Implications for Practice

    Sep 28, 2023·16m
  264. 264

    Biosimilars 101: From Neurologists, for Neurologists

    Sep 28, 2023·38m
  265. 265

    Optimizing Immunotherapy Combination Strategies for Metastatic NSCLC: From Evidence to Practice

    Sep 28, 2023·36m
  266. 266

    Diabetes Dialogue: Breaking Down Barriers to the Early Use of GLP-1 RAs in Primary Care

    Sep 22, 2023·16m
  267. 267

    COVID-19 and Antivirals: Expert Evaluation of Data in High-Risk Patient Populations

    Sep 20, 2023·32m
  268. 268

    New Lipid-Lowering Therapies in Atherosclerotic Cardiovascular Disease: Who, How, When, and for How Long?

    Sep 14, 2023·17m
  269. 269

    Early-Onset Schizophrenia: Integrated Service Provision and Optimizing Care

    Sep 4, 2023·19m
  270. 270

    Retinal Disease: An Update on Emerging Technologies

    Aug 31, 2023·51m
  271. 271

    COVID-19 in the Current Era: Expert Insights on Oral Antivirals for Nonhospitalized Patients

    Aug 28, 2023·57m
  272. 272

    Generalized Pustular Psoriasis: What Do You Know About the Unmet Needs for Patients?

    Aug 28, 2023·30m
  273. 273

    The Simple Mathematics of Lipid-Lowering Therapies and Targets in ASCVD: What Every Healthcare Professional Needs to Know

    Aug 18, 2023·34m
  274. 274

    Advances in the Management of Immunoglobulin G-Mediated Autoimmune Diseases

    Aug 14, 2023·30m
  275. 275

    Managing Generalized Pustular Psoriasis: A Micro Learning Series

    Aug 11, 2023·34m
  276. 276

    BTK Inhibitors for Chronic Lymphocytic Leukemia: Rapid-Fire Highlights From the Past Year

    Aug 11, 2023·19m
  277. 277

    Sudden Unexpected Death in Epilepsy (SUDEP): The Essentials for Sensitive and Informed Conversations

    Aug 4, 2023·37m
  278. 278

    Navigating the Changing Landscape in Myasthenia Gravis: An Expert Case-Based Discussion

    Jul 17, 2023·36m
  279. 279

    Finding the Needle in the Haystack: Following the Journey of a Patient With C3G

    Jul 13, 2023·34m
  280. 280

    Nutrients and Infant Neurodevelopment: Comparative Assessment on Impact of Individual Nutrients Over the Long Term

    Jun 30, 2023·23m
  281. 281

    Latest Advances in Systemic Treatment for Breast Cancer: Evidence and Implications

    Jun 30, 2023·41m
  282. 282

    Managing Early-Stage Resectable Non-Small Cell Lung Cancer: Through the Eyes of the Patient and the Care Team

    Jun 30, 2023·36m
  283. 283

    Clinical Pearls: Getting Low-Density Lipoprotein-Cholesterol Levels to Target and Keeping Them There

    Jun 30, 2023·50m
  284. 284

    Neonatal Fc Receptor in IgG-Mediated Autoimmune Disorders: Looking at a Common Denominator

    Jun 30, 2023·39m
  285. 285

    Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer

    Jun 28, 2023·19m
  286. 286

    Optimizing Treatment Selection in Immune Thrombocytopenia: A Patient Case Discussion

    Jun 27, 2023·34m
  287. 287

    Epilepsy and Its Burden: The Voice of the Caregiver

    Jun 26, 2023·20m
  288. 288

    Development of Heart Failure Following Myocardial Infarction: What Is the Unmet Need?

    Jun 23, 2023·16m
  289. 289

    Impact of Nutritional Management for Cow's Milk Allergy: Can It Interrupt the Allergic March?

    Jun 23, 2023·34m
  290. 290

    Long-Term Management of Reflux and Deprescribing PPI Therapy: Expert Perspectives

    Jun 22, 2023·32m
  291. 291

    Dengue: Vaccinating Travelers to Endemic Regions

    Jun 19, 2023·16m
  292. 292

    A Patient With Type 2 Diabetes and Chronic Kidney Disease in Clinical Practice

    Jun 16, 2023·22m
  293. 293

    Demystifying the Science of New Anti-Seizure Medications and Application to Clinical Practice

    Jun 16, 2023·30m
  294. 294

    Development of Heart Failure Following Myocardial Infarction: Why Risks Still Remain High

    Jun 15, 2023·20m
  295. 295

    Meeting the Experts and Taking Action in Heart Failure

    Jun 14, 2023·23m
  296. 296

    Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer

    Jun 14, 2023·35m
  297. 297

    Classification and Nomenclature of IC-MPGN and C3G: A Spectrum of Diseases or Distinct Entities?

    Jun 9, 2023·23m
  298. 298

    Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

    Jun 6, 2023·38m
  299. 299

    Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

    Jun 6, 2023·38m
  300. 300

    Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams

    May 31, 2023·43m
  301. 301

    A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better?

    May 31, 2023·27m
  302. 302

    Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations

    May 22, 2023·38m
  303. 303

    Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives

    May 8, 2023·35m
  304. 304

    Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit

    May 3, 2023·36m
  305. 305

    Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV

    May 1, 2023·33m
  306. 306

    Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a)

    Apr 18, 2023·41m
  307. 307

    Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic?

    Apr 14, 2023·38m
  308. 308

    What's New in Diabetic Eye Disease Technologies

    Mar 31, 2023·35m
  309. 309

    Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

    Mar 30, 2023·38m
  310. 310

    Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch

    Mar 29, 2023·1h 1m
  311. 311

    Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    Mar 29, 2023·35m
  312. 312

    Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

    Mar 28, 2023·35m
  313. 313

    Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies

    Mar 27, 2023·18m
  314. 314

    Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm

    Mar 27, 2023·37m
  315. 315

    Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?

    Mar 24, 2023·19m
  316. 316

    Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight

    Mar 23, 2023·21m
  317. 317

    Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?

    Mar 16, 2023·27m
  318. 318

    What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?

    Mar 16, 2023·37m
  319. 319

    Pros and Cons of COVID-19 Vaccination in Children: Weighing the Evidence

    Mar 2, 2023·38m
  320. 320

    The Road to Safety: Understanding the Common and Less Common Side Effects of COVID-19 and Other Vaccines

    Feb 28, 2023·39m
  321. 321

    Recovering Immune Responses in Heavily Treatment-Experienced HIV-Positive Individuals

    Feb 14, 2023·17m
  322. 322

    COVID-19 Immunization in Oncology and Stem Cell Transplant Settings: Experts Provide Practical Guidance

    Feb 13, 2023·33m
  323. 323

    Chronic Kidney Disease – Looking Beyond Diabetes: Expert Interpretation of Latest Evidence From Kidney Outcome Trials

    Feb 8, 2023·16m
  324. 324

    Dengue Immunization: Special Populations

    Feb 3, 2023·33m
  325. 325

    Evolving Hesitancies and Objections to COVID-19 Booster Shots: Separating Facts From Fiction

    Jan 31, 2023·41m
  326. 326

    Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications

    Jan 31, 2023·33m
  327. 327

    Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape

    Jan 26, 2023·36m
  328. 328

    Advanced Age-Related Macular Degeneration: How to Use Imaging to Screen and Monitor Patients

    Jan 23, 2023·34m
  329. 329

    Insights and Understanding of the Impact of Inflammation in HIV-Positive Individuals

    Jan 23, 2023·30m
  330. 330

    Ideal Dengue Vaccine Characteristics

    Jan 10, 2023·17m
  331. 331

    Where Are We Now in the Use of Interleukin-17 Inhibitors for Psoriatic Disease?

    Jan 4, 2023·39m
  332. 332

    Spotlight on Chronic Lymphocytic Leukemia: Exploring the Continued Evolution of Bruton Tyrosine Kinase Inhibitors for Our Patients

    Jan 4, 2023·29m
  333. 333

    Improving the Diagnosis and Management of Cow's Milk Allergy

    Jan 3, 2023·38m
  334. 334

    The Evolving Role of Digital Health Solutions for Patients With Diabetes on Insulin

    Dec 29, 2022·17m
  335. 335

    The Latest Data on Lipid-Lowering Therapies for ASCVD and What it Means for Practicing Clinicians

    Dec 28, 2022·26m
  336. 336

    What COVID-19 Vaccines Can and Cannot Do: Setting Realistic Goals in the Current Pandemic

    Dec 28, 2022·35m
  337. 337

    EMPA-Kidney in Context: Expanding Our Understanding of Sodium-Glucose Cotransporter 2 Inhibition in Chronic Kidney Disease Management

    Dec 28, 2022·45m
  338. 338

    COVID-19 Vaccine Clinical Compendium: Comparing Vaccines, Safety Status, and Future Perspectives

    Dec 27, 2022·34m
  339. 339

    To Boost or Not to Boost: The Debate Continues

    Dec 22, 2022·31m
  340. 340

    Advances in the Management of Complement-Mediated Kidney Diseases: A Year in Review

    Dec 15, 2022·18m
  341. 341

    Geographic Atrophy: Expert Perspectives and Latest Data

    Dec 13, 2022·46m
  342. 342

    Axial Spondyloarthritis: What Do You Know?

    Dec 12, 2022·21m
  343. 343

    Complex Clinical Cases for Specialists: Getting Patients to Target LDL-C Despite Barriers

    Dec 12, 2022·31m
  344. 344

    Raising the Bar: Implementing Treatment Goals in Clinical Practice for Spondyloarthritis

    Dec 9, 2022·1h 33m
  345. 345

    COVID-19 Boosters: Why Do We Need Them?

    Dec 1, 2022·37m
  346. 346

    Why Lipoprotein (a) Matters Regarding Cardiovascular Risk, and What's New?

    Nov 29, 2022·29m
  347. 347

    Understanding the Impact of Hidradenitis Suppurativa on Patients' Lives

    Nov 28, 2022·30m
  348. 348

    Urticaria in Minutes: Key Topics in the Diagnosis, Assessment, and Management of Chronic Spontaneous Urticaria

    Nov 28, 2022·44m
  349. 349

    RET Inhibitors for RET-Altered Non-Small Cell Lung Cancer: Identification, Treatment, and Practicalities

    Nov 22, 2022·33m
  350. 350

    Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow

    Nov 8, 2022·1h 32m
  351. 351

    Latest Perspectives for Managing EGFR TKI-Refractory and Resistant Non-Small Cell Lung Cancer: Updates From the European Oncology Congress

    Nov 2, 2022·36m
  352. 352

    Latest Perspectives for Managing EGFR TKI-Refractory and Resistant Non-Small Cell Lung Cancer: Updates From the European Oncology Congress

    Nov 2, 2022·36m
  353. 353

    New Frontiers in Neutrophilic Dermatoses: Role of the IL-36 Pathway

    Oct 31, 2022·30m
  354. 354

    A Case-Based Approach: Implementing Patient-Centered Care in Reflux Disease

    Oct 6, 2022·37m
  355. 355

    Quizzing the Experts: Why Is Combination Therapy in Dyslipidemia Started Too Late, and Why Does It Matter?

    Sep 27, 2022·30m
  356. 356

    Is Chronic Pain Avoidable? A 3-Tiered Approach to Prevent Chronicity – Assess/Manage/Communicate

    Sep 22, 2022·36m
  357. 357

    Wilson Disease Yesterday, Today, and Tomorrow: Following a Patient's Journey

    Sep 21, 2022·45m
  358. 358

    Tools to Get to LDL-C Target With Better Adherence: The Experts Share Experiences With New Therapies

    Sep 21, 2022·48m
  359. 359

    COVID-19 Bivalent mRNA Vaccines: Covering Variants in the Transition to Endemicity

    Sep 20, 2022·37m
  360. 360

    Diagnosis and Management of C3G: A Collaborative Effort Between Pathologists and Nephrologists

    Sep 15, 2022·29m
  361. 361

    Obesity and CV Disease: Lowering CV Risk With Novel Weight Loss Strategies

    Sep 15, 2022·1h 3m
  362. 362

    Modernizing the Management of Heart Failure: Implementation Is Critical to Success

    Sep 14, 2022·50m
  363. 363

    An Update on C3 Glomerulopathy: Understanding a Rare Complement-Mediated Kidney Disease

    Sep 2, 2022·36m
  364. 364

    Not Just Dry Eye: Everyday Case Challenges

    Aug 31, 2022·30m
  365. 365

    Clinical Pearls on the Management of Wilson Disease With Neurological Features

    Aug 26, 2022·22m
  366. 366

    Management of Wilson Disease in the Gastroenterology Setting: Guidance on Current Clinical Strategies

    Aug 26, 2022·17m
  367. 367

    Genetic Counselling for Leber Hereditary Optic Neuropathy Patients and Their Families

    Aug 19, 2022·34m
  368. 368

    Getting Social About Constipation: Enhancing the Patient-Provider Dialogue

    Aug 18, 2022·42m
  369. 369

    "Life Can Only Be Understood Backwards, But It Must Be Lived Forwards": Major Depressive Disorder Today and Tomorrow

    Aug 16, 2022·36m
  370. 370

    We've Seen All the Data, But How Do We Now Treat Heart Failure: A Case-Based Approach

    Aug 10, 2022·37m
  371. 371

    Dengue: A Burden Throughout the Life Course

    Aug 3, 2022·29m
  372. 372

    Wilson Disease: A Challenging Diagnosis in the Neurology Setting

    Jul 29, 2022·23m
  373. 373

    Wilson Disease: A Challenging Diagnosis in the Gastroenterology Setting

    Jul 29, 2022·24m
  374. 374

    Pediatric COVID-19 Vaccination: Expert Perspectives and Data Analysis

    Jul 27, 2022·37m
  375. 375

    Tackling the Obesity Pandemic: The Central Role of the Primary Care Physician

    Jul 27, 2022·17m
  376. 376

    Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis

    Jul 26, 2022·37m
  377. 377

    Driving Evidence-Based Treatment: The Role of the Thoracic Multidisciplinary Team in Early-Stage Lung Cancer

    Jul 22, 2022·37m
  378. 378

    A Wolf in Sheep's Clothing: The Spectrum of Morbidity Due to Epstein-Barr Virus

    Jul 19, 2022·41m
  379. 379

    Three's a Crowd: The Interaction Between RSV, Immune Responses, and Frailty

    Jul 13, 2022·30m
  380. 380

    Quickfire Updates From Chicago: What's New for EGFR TKI Refractory and Resistant Non-Small Cell Lung Cancer?

    Jul 11, 2022·19m
  381. 381

    Suspecting RSV in Older Adults: Clinical Signs and What to Seek

    Jul 1, 2022·17m
  382. 382

    Wilson Disease: The Great Masquerader

    Jun 30, 2022·48m
  383. 383

    Seizure Freedom for Patients with Focal Seizures: Can We Aim Higher?

    Jun 30, 2022·38m
  384. 384

    Complement in Rare Kidney Diseases: Different Diseases With a Common Denominator

    Jun 29, 2022·32m
  385. 385

    Countdown to Knowledge of Novel Therapies for Generalized Pustular Psoriasis Flares

    Jun 29, 2022·21m
  386. 386

    My Challenges and Hopes for a Better Life With Major Depressive Disorder: The Voice of the Patient

    Jun 29, 2022·28m
  387. 387

    Obesity Talk (Episode 2): Opportunities for the Use of Novel Anti-Obesity Medications in Clinical Practice?

    Jun 28, 2022·20m
  388. 388

    Optimizing Outcomes With Biologic Therapies in Psoriatic Disease

    Jun 28, 2022·51m
  389. 389

    Seismic Shifts in Heart Failure Management: How Sodium-Glucose Cotransporter-2 Inhibitors Are Changing How We Treat Our Patients

    Jun 27, 2022·44m
  390. 390

    Targeting Angiopoietin-2: A New Approach in Retinal Diseases

    Jun 24, 2022·26m
  391. 391

    How to Assess and Diagnose Food Allergies: Experts Discuss Best Practices and Recent Advancements

    Jun 23, 2022·35m
  392. 392

    Advanced Age-Related Macular Degeneration: Assessment, Strategies, and New Therapies

    Jun 21, 2022·31m
  393. 393

    Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic

    Jun 21, 2022·41m
  394. 394

    Extending Horizons With Immune Checkpoint Inhibitors in Small Cell Lung Cancer: 2022 Perspectives

    Jun 17, 2022·40m
  395. 395

    Clinical Perspectives on HER2-Targeted Antibody-Drug Conjugates: Treatment-Related Adverse Events

    Jun 15, 2022·38m
  396. 396

    International Heart Failure Guidelines and the Latest Data: Out of Complexities, Simplicities Emerge With SGLT2 Inhibitors

    Jun 14, 2022·34m
  397. 397

    Epilepsy and Depression: Early Recognition or Double Trouble?

    Jun 13, 2022·34m
  398. 398

    Addressing the Challenge of Endocrine-Resistant Breast Cancer

    Jun 2, 2022·38m
  399. 399

    Addressing the Challenge of HER2 Heterogeneity in Breast Cancer

    Jun 1, 2022·35m
  400. 400

    RSV: Omnipresent and Inescapable

    May 27, 2022·19m
  401. 401

    Management Strategies to Optimize Outcomes in CKD-aP: A Case-Based Discussion

    May 27, 2022·34m
  402. 402

    The Molecular Tumor Board: Best Practices for Managing Primary and Acquired EGFR TKI Resistance

    May 24, 2022·45m
  403. 403

    The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?

    May 17, 2022·29m
  404. 404

    Managing Psoriatic Disease With Biologic Therapies

    May 12, 2022·35m
  405. 405

    Leber Hereditary Optic Neuropathy Gene Therapy – Who Should Be Treated and How?

    May 11, 2022·31m
  406. 406

    Evolving Perspectives on How to Achieve Successful Outcomes in Crohn Disease

    May 10, 2022·31m
  407. 407

    Immunopathogenesis of Hidradenitis Suppurativa

    May 10, 2022·26m
  408. 408

    Treat Across the Heart Failure Spectrum or Dichotomize by Ejection Fraction Category? The Experts Debate

    May 4, 2022·35m
  409. 409

    Emerging Treatment Options for CKD-Associated Pruritis: Focus on Kappa Opioid Receptors

    May 3, 2022·37m
  410. 410

    The Patient With Chronic Ocular Surface Pain: Taking the Next Step

    May 3, 2022·38m
  411. 411

    Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and Implications

    May 2, 2022·1h 37m
  412. 412

    CAR T-Cell Therapy for R/R Multiple Myeloma: Sharing Expert Insights to Advance Outcomes

    Apr 27, 2022·36m
  413. 413

    Geographic Atrophy: Complement Inhibitors and Implications for Clinical Practice

    Apr 27, 2022·32m
  414. 414

    What's New in Biologic Therapies for Crohn Disease? An Update From Vienna

    Apr 26, 2022·18m
  415. 415

    COVID-19 Vaccination in the Elderly: Experts Discuss Challenges and Current Recommendations

    Apr 25, 2022·32m
  416. 416

    My Patient on Hemodialysis Has Itch Symptoms: What Should I Do?

    Apr 15, 2022·46m
  417. 417

    Obesity Talk (Episode 1): How to Start a Conversation About Obesity With Your Patient?

    Apr 14, 2022·16m
  418. 418

    Early Biologic Choice in Crohn Disease: Setting the Stage for Successful Outcomes

    Apr 14, 2022·22m
  419. 419

    Clinical Controversies on NASH: Quick Questions – Rapid Replies

    Apr 8, 2022·19m
  420. 420

    The Beast With a Thousand Heads: Dispelling Myths and Misinformation Around COVID-19 Vaccines With Scientific Data

    Apr 5, 2022·42m
  421. 421

    Immunoglobulin A Nephropathy: A Call to Action for Personalized Risk Assessment and Timely Management

    Apr 5, 2022·33m
  422. 422

    Hepatosplenomegaly, Thrombocytopenia, and Bone Pain: What Next?

    Apr 5, 2022·19m
  423. 423

    Herpes Zoster Immunization: Data Updates and Practice Essentials in the Current Landscape

    Apr 5, 2022·33m
  424. 424

    MEK Inhibitors for NF1-Related Plexiform Neurofibromas: An MDT Approach for Addressing Adverse Events, Adherence, and Patient Guidance

    Apr 5, 2022·32m
  425. 425

    Unfolding the Future: How Will mRNA Technology Change the Landscape of Vaccination?

    Mar 31, 2022·34m
  426. 426

    Generalized Pustular Psoriasis: Understanding the Patient Experience

    Mar 28, 2022·20m
  427. 427

    COVID-19 Vaccination of Immunocompromised Individuals: What Every Physician Should Know

    Mar 28, 2022·34m
  428. 428

    Building Confidence in COVID-19 Vaccines: Why Are Millennials Hesitant?

    Mar 25, 2022·19m
  429. 429

    Major Depressive Disorder as a Psychiatric Emergency: Identifying Who Is at Highest Risk

    Mar 25, 2022·34m
  430. 430

    Emerging From the Shadows: Expert Perspectives on the True Burden of RSV in Older Adults

    Mar 23, 2022·37m
  431. 431

    Relapsed/Refractory Multiple Myeloma and CAR T-Cell Therapy: Navigating the Patient Journey

    Mar 23, 2022·35m
  432. 432

    COVID-19 Vaccine Effectiveness in Variants of Concern: What Do We Currently Know?

    Mar 23, 2022·36m
  433. 433

    The A to Z of Congenital Cytomegalovirus: Epidemiology, Burden of Disease, and Diagnosis

    Mar 23, 2022·34m
  434. 434

    Neuro-Diabetes Crosstalk – Strategies for Stroke Prevention in Type 2 Diabetes

    Mar 23, 2022·17m
  435. 435

    My Life With Uncontrolled Focal Seizures: The Voice of the Patient

    Mar 22, 2022·31m
  436. 436

    Lifting the Load of Comorbidities in Women Living With HIV: Raising Awareness and Optimizing Care

    Mar 22, 2022·40m
  437. 437

    COVID-19 Vaccination in Children: Experts Weigh In on the Evidence So Far

    Mar 16, 2022·39m
  438. 438

    New Frontiers in Retina: Experts Discuss Novel Therapies & Technologies

    Mar 14, 2022·55m
  439. 439

    Building Confidence in COVID-19 Vaccines: How to Talk to Your Younger Adults

    Mar 8, 2022·16m
  440. 440

    Can You Recognize and Diagnose Generalized Pustular Psoriasis (GPP)?

    Feb 28, 2022·39m
  441. 441

    Inertia In Major Depressive Disorder: A Journey of a Thousand Miles Begins With a Single Step

    Feb 25, 2022·33m
  442. 442

    Re-Examining Multidrug Resistance in Heavily Pretreated PLWHIV With Few Antiretroviral Therapy Options

    Feb 23, 2022·20m
  443. 443

    Fresh Perspectives on Geographic Atrophy: New Drugs and Latest Data

    Feb 18, 2022·46m
  444. 444

    Milestones in COVID-19 mRNA Vaccine Development: How Did We Develop It so Quickly?

    Feb 16, 2022·33m
  445. 445

    The Evolution in Systemic Breast Cancer Therapies: A Deeper Dive Into Recent Data

    Feb 15, 2022·33m
  446. 446

    Deconstructing COVID-19 Vaccine Hesitancy: Providing Tailored Solutions Across the Spectrum

    Feb 14, 2022·40m
  447. 447

    Immunotherapies in Relapsed/Refractory Multiple Myeloma: 2021 Round-Up and a Look Into the Future

    Feb 7, 2022·34m
  448. 448

    The COVID-19 mRNA Vaccines: How Do They Work?

    Feb 7, 2022·29m
  449. 449

    Screening for Nonalcoholic Steatohepatitis in the Patient With Metabolic Disorders

    Feb 1, 2022·16m
  450. 450

    Evolving Best Practices for Managing AL Amyloidosis: Sharing Perspectives

    Feb 1, 2022·32m
  451. 451

    Throughout a Lifetime: The Intersection of HIV and Biological Considerations in Women Living With HIV

    Jan 28, 2022·28m
  452. 452

    Evolution or Revolution in HFrEF: What Now for Our Patients?

    Jan 27, 2022·34m
  453. 453

    Early-Onset Schizophrenia in a New Light: A Patient's Testimony

    Jan 26, 2022·38m
  454. 454

    Beyond Post-Herpetic Neuralgia: Awareness of Other Complications Associated with Herpes Zoster

    Jan 25, 2022·36m
  455. 455

    Beyond Clinical Trials: What Does Real-World Evidence Tell Us About COVID-19 mRNA Vaccine Effectiveness and Safety?

    Jan 24, 2022·30m
  456. 456

    To Boost or Not to Boost: What Does the Evidence Tell Us?

    Jan 13, 2022·36m
  457. 457

    Failure to Recover CD4 in People Living With HIV: Clarifying the Causes and Related Consequences

    Jan 5, 2022·32m
  458. 458

    Recognizing the Risk of Herpes Zoster in Older Adults With Comorbidities

    Jan 5, 2022·17m
  459. 459

    Stepping Stones to Long-Term Obesity Management

    Jan 4, 2022·22m
  460. 460

    Improving on the Past: Using Next-Generation BTK Inhibitors Effectively in B-Cell Malignancies

    Jan 3, 2022·39m
  461. 461

    SGLT2 Inhibitors and Other Classes of Therapies in HFpEF: Examining The Totality of Clinical Data

    Dec 27, 2021·32m
  462. 462

    Reviewing Outcomes for HFpEF With SGLT2 Inhibitors: A Data Deep Dive

    Dec 27, 2021·32m
  463. 463

    News on NASH – Selected Highlights from The Liver Meeting 2021

    Dec 27, 2021·53m
  464. 464

    Dengue: Strategies to Limit Human Exposure to Disease-Carrying Mosquitos

    Dec 22, 2021·33m
  465. 465

    New Treatment Approaches for Geographic Atrophy: Focus on the Complement Cascade

    Dec 22, 2021·36m
  466. 466

    Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care?

    Dec 21, 2021·36m
  467. 467

    Sorting Out Sore Throats: Role of Nonsteroidal Anti-Inflammatory Lozenges

    Dec 7, 2021·28m
  468. 468

    Examining the Latest European HFrEF Guidelines: Putting the Patient at the Center of Management

    Dec 7, 2021·34m
  469. 469

    Diabetes Dialogue: Incretin Therapy According to Guidelines

    Dec 2, 2021·17m
  470. 470

    Breast Cancer in 2021: Where Do We Stand, and What Is Yet to Come?

    Dec 1, 2021·16m
  471. 471

    Updates in Chronic Spontaneous Urticaria From EADV: Experts Highlight the Latest Advances

    Nov 30, 2021·45m
  472. 472

    Emerging Science Across the Spectrum of Breast Cancer: Latest Perspectives

    Nov 30, 2021·36m
  473. 473

    HFrEF Guideline Recommendations in Practice: Living Life Forward

    Nov 29, 2021·34m
  474. 474

    My Patient on Hemodialysis Has Itch Symptoms: How Concerned Should I Be?

    Nov 29, 2021·29m
  475. 475

    HIV and Inflammation: Raising Awareness of the Impact of Inflammation on People Living With HIV

    Nov 24, 2021·35m
  476. 476

    Walking Through the Major Changes in Heart Failure: Definitions, Guidelines, and Impact of Management

    Nov 22, 2021·35m
  477. 477

    Fundamental Facts About Glucagon-Like Peptide-1 Receptor Agonists for the Diabetologist – Quick Questions / Rapid Replies

    Nov 17, 2021·18m
  478. 478

    B-Cell Malignancies: Why Not All BTK Inhibitors Are Created Equal

    Nov 16, 2021·47m
  479. 479

    Optimizing the Nutritional Care of Preterm Infants

    Nov 15, 2021·50m
  480. 480

    Updated Guidelines for Heart Failure With Reduced Ejection Fraction: Squinting Through the Fog

    Nov 10, 2021·29m
  481. 481

    Zooming in on Cardiovascular Risk Control With Glucagon-Like Peptide-1 Receptor Agonists in Diabetes

    Nov 8, 2021·17m
  482. 482

    Optimizing Outcomes in Diabetic Macular Edema: Why Fluid Matters

    Nov 4, 2021·34m
  483. 483

    Can You Recognize and Diagnose CKD-aP?

    Nov 1, 2021·28m
  484. 484

    Managing Cardiometabolic & COVID-19 Risks in Diabetes – A Vital News Bulletin for the Cardiologist

    Oct 29, 2021·20m
  485. 485

    Neurodevelopmental Outcomes and Nutritional Strategies in Infants

    Oct 29, 2021·30m
  486. 486

    Challenges and Opportunities in the Management of Psoriasis: The Evolving Treatment Landscape

    Oct 29, 2021·15m
  487. 487

    Emerging Systemic Treatment Options Across the Spectrum of Breast Cancer Therapy

    Oct 27, 2021·37m
  488. 488

    Understanding Geographic Atrophy: Disease Facts, Pathophysiology, Diagnosis, and Monitoring

    Oct 25, 2021·51m
  489. 489

    Vitreoretinal Surgery Considerations for Novel Drug Technologies

    Oct 21, 2021·33m
  490. 490

    Managing the Patient With DME: What's on the Horizon?

    Oct 21, 2021·38m
  491. 491

    Mosquito-Borne Viral Diseases: Advice for Travelers to Endemic Areas

    Oct 15, 2021·35m
  492. 492

    Why Should We Test for Lipoprotein(a)? The Experts Discuss

    Oct 13, 2021·34m
  493. 493

    The Paramount Principles of Incretin Therapy: A Formula for Success in Primary Care

    Oct 13, 2021·20m
  494. 494

    The Foundations of Immunization: What, Who, When and Why?

    Sep 30, 2021·18m
  495. 495

    Changing Practice in Advanced/Metastatic Cholangiocarcinoma: What Clinicians Need to Know

    Sep 28, 2021·38m
  496. 496

    From Genes to Cardiovascular Events: What All Physicians Need to Know About Lp(a)

    Sep 27, 2021·50m
  497. 497

    Integrating Novel Therapies in the Management of Severe Asthma: Experts Discuss Challenging Cases

    Sep 24, 2021·28m
  498. 498

    Evolving Understanding on COVID-19 Vaccines and SARS-CoV-2 Variants

    Sep 23, 2021·42m
  499. 499

    COPD: ICS Pros and Cons in Primary Care

    Sep 23, 2021·18m
  500. 500

    Essential Facts About Dual Incretin Receptor Agonists – Quick Questions, Rapid Replies

    Sep 22, 2021·19m